Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
HCG (Human Chorionic Gonadotropin) vs Testosterone (TRT): Testosterone (TRT) has the stronger overall evidence (5.6 vs 5.5/10); they're alternatives for libido & male vitality — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Testosterone (TRT) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both HCG (Human Chorionic Gonadotropin) and Testosterone (TRT) have evidence — compare verdict strength side-by-side.
Prescription-only and indication-dependent. For intratesticular-testosterone maintenance on TRT, the cited studies used 125-500 IU every other day (intramuscular in the one that states the route). For spermatogenesis induction in hypogonadotropic hypogonadism, typically ~1,000-2,500 IU two to three times weekly (often combined with FSH), titrated to response. For female ovulation/oocyte-maturation trigger, a single dose (~5,000-10,000 IU urinary or 250 µg recombinant). No cited study gives these two doses. No dietary-supplement dose exists.
Any time of day
Prescription hCG — recombinant (choriogonadotropin alfa) or urinary-derived, by injection
Prescription-only and clinician-directed — this is a controlled substance, NOT a self-administered supplement, and we do not provide a non-medical dosing protocol. For context only: TRT for diagnosed hypogonadism is titrated to a mid-normal testosterone level. Intramuscular testosterone esters (cypionate/enanthate) are commonly dosed around 50–100 mg weekly (or ~100–200 mg every 2 weeks); long-acting testosterone undecanoate is dosed less frequently. Transdermal gels (~50–100 mg/day applied) and subcutaneous injection are alternative routes. Supraphysiologic anabolic-steroid doses are far higher and dangerous — not a regimen this library endorses.
Any time of day
Clinician-prescribed testosterone (intramuscular ester or transdermal gel) for diagnosed hypogonadism — controlled substance, prescription-only
and 1 more not shown
and 1 more not shown
Weeks
Months
Months
Within ~36 hours
Weeks to months
Months
Months
Throughout use
Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.
J Clin Endocrinol Metab (2005) · Rct · n=29
29 men with normal reproductive physiology randomized to weekly testosterone enanthate plus saline placebo or 125, 250, or 500 IU hCG every other day for 3 weeks
Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
J Urol (2013) · Observational · n=26
Retrospective cohort of 26 hypogonadal men on testosterone replacement plus 500 IU intramuscular hCG every other day, mean follow-up 6.2 months
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Fertil Steril (2009) · Observational · n=100
Combined analysis of four Phase III open-label studies in 100 men with complete idiopathic or acquired hypogonadotropic hypogonadism, pretreated with hCG for 3-6 months then hCG plus recombinant FSH
Effects of Testosterone Treatment in Older Men.
The New England journal of medicine (2016) · Rct · n=790
The coordinated Testosterone Trials: 790 men aged 65 or older with testosterone below 275 ng/dl and symptoms, testosterone gel or placebo gel for one year, each man in one or more of the Sexual Function, Physical Function and Vitality Trials.
Cardiovascular Safety of Testosterone-Replacement Therapy.
The New England journal of medicine (2023) · Rct · n=5246
TRAVERSE: a randomized, double-blind, placebo-controlled noninferiority trial of daily 1.62% testosterone gel in 5,246 men aged 45 to 80 with hypogonadism and existing or high risk of cardiovascular disease, mean follow-up 33 months.
Safety and Efficacy of Testosterone Therapy on Musculoskeletal Health and Clinical Outcomes in Men: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Endocrine practice (2023) · Meta analysis · n=1728
Systematic review and meta-analysis of 16 randomized placebo-controlled trials (1,728 men, mean age 77) of testosterone therapy on bone, muscle, fat and strength.
Testosterone (TRT) has a higher evidence score (5.6/10 vs 5.5/10) and wins in 2 of 3 categories.
For libido & male vitality, Testosterone (TRT) has a higher relevance score (68 vs 50).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.